Clinical trials: Tace

Metastatic Colorectal Cancer

HepaSphere™ Microspheres Prospective Registry

• Completed
• Age: All ages
• Observational study
• Medical device
• Results posted

HepaSphere™ Microspheres loaded with irinotecan received CE mark for the indication of use in embolization of metastatic colorectal cancer (mCRC) to the liver in 2015.

Trial name

mCRC (NCT04866290)

Testing

HepaSphere Microspheres

Where

2 sites in France, Greece

Volunteers

105 people

Sponsor

Merit Medical Systems, Inc.